| Gene symbol | TNFRSF8 | Synonyms | CD30, D1S166E, Ki-1 | Type of gene | protein-coding |
| Chromosome | 1 | Map location | 1p36.22 | dbXrefs | |
| Description | TNF receptor superfamily member 8 | ||||
| GTO ID | GTC3692 |
| Trial ID | NCT06176690 |
| Disease | Diffuse Large B-Cell Lymphoma | Anaplastic Large Cell Lymphoma | T-Cell Lymphoma | Non-Hodgkin's Lymphoma | Hodgkin's Lymphoma |
| Altered gene | CD30 |
| Therapeutic/Target gene | Target gene |
| Therapy | CAR-T cell |
| Treatment | C7R.CD30.CAR-EBVST cells |
| Phase | Phase1 |
| Recruitment status | Not Recruiting |
| Title | Constitutive IL7R (C7R) Modified Banked Allogeneic CD30 Chimeric Antigen Receptor Epstein-Barr Virus-Specific T Lymphocytes (CD30.CAR-EBVSTs) in Patients With Relapsed or Refractory CD30-Positive Lymphomas |
| Year | 2024 |
| Country | United States |
| Company sponsor | Baylor College of Medicine |
| Other ID(s) | H-54063, CABAL |
| Cohort 1 | |||||||||||||
|
|||||||||||||